Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series
Identifieur interne : 000304 ( Pmc/Checkpoint ); précédent : 000303; suivant : 000305Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series
Auteurs : J. Van De Leemput [États-Unis, Royaume-Uni] ; F. Wavrant-De Vrièze [États-Unis] ; I. Rafferty [États-Unis] ; Jm Bras [États-Unis] ; P. Giunti [Royaume-Uni] ; Emc Fisher [Royaume-Uni] ; J. Hardy [Royaume-Uni] ; Ab Singleton [États-Unis] ; H. Houlden [Royaume-Uni]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2010.
Abstract
Spinocerebellar ataxia type 15 and 16 (SCA15/16) are autosomal dominant cerebellar ataxias that are slowly progressive with a predominantly pure ataxia phenotype (ADCA III). The locus for SCA15 was first mapped to 3p24.2–3pter and subsequently full or partial deletions in the
Url:
DOI: 10.1002/mds.22970
PubMed: 20437544
PubMed Central: 2864955
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:2864955Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sequencing analysis of the <italic>ITPR1</italic>
gene in a pure autosomal dominant spinocerebellar ataxia series</title>
<author><name sortKey="Van De Leemput, J" sort="Van De Leemput, J" uniqKey="Van De Leemput J" first="J" last="Van De Leemput">J. Van De Leemput</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3"> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wavrant De Vrieze, F" sort="Wavrant De Vrieze, F" uniqKey="Wavrant De Vrieze F" first="F" last="Wavrant-De Vrièze">F. Wavrant-De Vrièze</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rafferty, I" sort="Rafferty, I" uniqKey="Rafferty I" first="I" last="Rafferty">I. Rafferty</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bras, Jm" sort="Bras, Jm" uniqKey="Bras J" first="Jm" last="Bras">Jm Bras</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Giunti, P" sort="Giunti, P" uniqKey="Giunti P" first="P" last="Giunti">P. Giunti</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fisher, Emc" sort="Fisher, Emc" uniqKey="Fisher E" first="Emc" last="Fisher">Emc Fisher</name>
<affiliation wicri:level="1"><nlm:aff id="A3"> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hardy, J" sort="Hardy, J" uniqKey="Hardy J" first="J" last="Hardy">J. Hardy</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Singleton, Ab" sort="Singleton, Ab" uniqKey="Singleton A" first="Ab" last="Singleton">Ab Singleton</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Houlden, H" sort="Houlden, H" uniqKey="Houlden H" first="H" last="Houlden">H. Houlden</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20437544</idno>
<idno type="pmc">2864955</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864955</idno>
<idno type="RBID">PMC:2864955</idno>
<idno type="doi">10.1002/mds.22970</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">000090</idno>
<idno type="wicri:Area/Pmc/Curation">000090</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000304</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Sequencing analysis of the <italic>ITPR1</italic>
gene in a pure autosomal dominant spinocerebellar ataxia series</title>
<author><name sortKey="Van De Leemput, J" sort="Van De Leemput, J" uniqKey="Van De Leemput J" first="J" last="Van De Leemput">J. Van De Leemput</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3"> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wavrant De Vrieze, F" sort="Wavrant De Vrieze, F" uniqKey="Wavrant De Vrieze F" first="F" last="Wavrant-De Vrièze">F. Wavrant-De Vrièze</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rafferty, I" sort="Rafferty, I" uniqKey="Rafferty I" first="I" last="Rafferty">I. Rafferty</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bras, Jm" sort="Bras, Jm" uniqKey="Bras J" first="Jm" last="Bras">Jm Bras</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Giunti, P" sort="Giunti, P" uniqKey="Giunti P" first="P" last="Giunti">P. Giunti</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fisher, Emc" sort="Fisher, Emc" uniqKey="Fisher E" first="Emc" last="Fisher">Emc Fisher</name>
<affiliation wicri:level="1"><nlm:aff id="A3"> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hardy, J" sort="Hardy, J" uniqKey="Hardy J" first="J" last="Hardy">J. Hardy</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Singleton, Ab" sort="Singleton, Ab" uniqKey="Singleton A" first="Ab" last="Singleton">Ab Singleton</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea> Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Houlden, H" sort="Houlden, H" uniqKey="Houlden H" first="H" last="Houlden">H. Houlden</name>
<affiliation wicri:level="1"><nlm:aff id="A2"> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea> Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG</wicri:regionArea>
<wicri:noRegion>London WC1N 3BG</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Spinocerebellar ataxia type 15 and 16 (SCA15/16) are autosomal dominant cerebellar ataxias that are slowly progressive with a predominantly pure ataxia phenotype (ADCA III). The locus for SCA15 was first mapped to 3p24.2–3pter and subsequently full or partial deletions in the <italic>inositol 1,4,5-triphosphate receptor type 1</italic>
(<italic>ITPR1</italic>
) gene were identified in several ADCA III families that segregated with the disease. A single missense coding variant has been described, but the pathogenicity of this change has not been proven. We sequenced the entire coding region and flanking regions of <italic>ITPR1</italic>
in unrelated ADCA III families (<italic>n</italic>
=38) that were negative for large deletions on whole genome arrays, and for which SCAs 1, 2, 3, 6, 7, 8, 11, 12, 14, 17 and the Friedreich’s ataxia expansion were excluded in all probands. Mutation at SCA5, 10 and 27 was also excluded in some families. A number of coding and non-coding polymorphisms were identified but no <italic>ITPR1</italic>
mutations were found. The results indicate that point mutations in <italic>ITPR1</italic>
are at best a rare cause of ADCA III.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">8610688</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5937</journal-id>
<journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
<journal-title>Movement disorders : official journal of the Movement Disorder Society</journal-title>
<issn pub-type="ppub">0885-3185</issn>
<issn pub-type="epub">1531-8257</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">20437544</article-id>
<article-id pub-id-type="pmc">2864955</article-id>
<article-id pub-id-type="doi">10.1002/mds.22970</article-id>
<article-id pub-id-type="manuscript">NIHMS162159</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Sequencing analysis of the <italic>ITPR1</italic>
gene in a pure autosomal dominant spinocerebellar ataxia series</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>van de Leemput</surname>
<given-names>J</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Wavrant-De Vrièze</surname>
<given-names>F</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Rafferty</surname>
<given-names>I</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Bras</surname>
<given-names>JM</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Giunti</surname>
<given-names>P</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Fisher</surname>
<given-names>EMC</given-names>
</name>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Hardy</surname>
<given-names>J</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Singleton</surname>
<given-names>AB</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Houlden</surname>
<given-names>H</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, 35 Convent Drive, 20892, Bethesda, MD, USA</aff>
<aff id="A2"><label>2</label>
Department of Molecular Neuroscience and Reta Lila Weston Laboratories, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</aff>
<aff id="A3"><label>3</label>
Department of Neurodegenerative Disease, Institute of Neurology, UCL, Queen Square House, London WC1N 3BG, United Kingdom</aff>
<author-notes><corresp id="FN1">Correspondence: Dr. Andrew Singleton, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, 35 Convent Drive, Bethesda, MD 20892, USA, <email>singleta@mail.nih.gov</email>
telephone: 1 301 451 6079, fax: 1 301 451 7295</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>30</day>
<month>11</month>
<year>2009</year>
</pub-date>
<pub-date pub-type="ppub"><day>30</day>
<month>4</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>30</day>
<month>4</month>
<year>2011</year>
</pub-date>
<volume>25</volume>
<issue>6</issue>
<fpage>763</fpage>
<lpage>765</lpage>
<abstract><p id="P1">Spinocerebellar ataxia type 15 and 16 (SCA15/16) are autosomal dominant cerebellar ataxias that are slowly progressive with a predominantly pure ataxia phenotype (ADCA III). The locus for SCA15 was first mapped to 3p24.2–3pter and subsequently full or partial deletions in the <italic>inositol 1,4,5-triphosphate receptor type 1</italic>
(<italic>ITPR1</italic>
) gene were identified in several ADCA III families that segregated with the disease. A single missense coding variant has been described, but the pathogenicity of this change has not been proven. We sequenced the entire coding region and flanking regions of <italic>ITPR1</italic>
in unrelated ADCA III families (<italic>n</italic>
=38) that were negative for large deletions on whole genome arrays, and for which SCAs 1, 2, 3, 6, 7, 8, 11, 12, 14, 17 and the Friedreich’s ataxia expansion were excluded in all probands. Mutation at SCA5, 10 and 27 was also excluded in some families. A number of coding and non-coding polymorphisms were identified but no <italic>ITPR1</italic>
mutations were found. The results indicate that point mutations in <italic>ITPR1</italic>
are at best a rare cause of ADCA III.</p>
</abstract>
<kwd-group><kwd>ataxia</kwd>
<kwd>spinocerebellar</kwd>
<kwd>SCA15</kwd>
<kwd>genetics</kwd>
<kwd>inositol-1,4,5-triphosphate receptor type 1</kwd>
</kwd-group>
<contract-num rid="AG1">Z01 AG000957-06
||AG</contract-num>
<contract-sponsor id="AG1">National Institute on Aging : NIA</contract-sponsor>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Van De Leemput, J" sort="Van De Leemput, J" uniqKey="Van De Leemput J" first="J" last="Van De Leemput">J. Van De Leemput</name>
</region>
<name sortKey="Bras, Jm" sort="Bras, Jm" uniqKey="Bras J" first="Jm" last="Bras">Jm Bras</name>
<name sortKey="Rafferty, I" sort="Rafferty, I" uniqKey="Rafferty I" first="I" last="Rafferty">I. Rafferty</name>
<name sortKey="Singleton, Ab" sort="Singleton, Ab" uniqKey="Singleton A" first="Ab" last="Singleton">Ab Singleton</name>
<name sortKey="Wavrant De Vrieze, F" sort="Wavrant De Vrieze, F" uniqKey="Wavrant De Vrieze F" first="F" last="Wavrant-De Vrièze">F. Wavrant-De Vrièze</name>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Van De Leemput, J" sort="Van De Leemput, J" uniqKey="Van De Leemput J" first="J" last="Van De Leemput">J. Van De Leemput</name>
</noRegion>
<name sortKey="Fisher, Emc" sort="Fisher, Emc" uniqKey="Fisher E" first="Emc" last="Fisher">Emc Fisher</name>
<name sortKey="Giunti, P" sort="Giunti, P" uniqKey="Giunti P" first="P" last="Giunti">P. Giunti</name>
<name sortKey="Hardy, J" sort="Hardy, J" uniqKey="Hardy J" first="J" last="Hardy">J. Hardy</name>
<name sortKey="Houlden, H" sort="Houlden, H" uniqKey="Houlden H" first="H" last="Houlden">H. Houlden</name>
<name sortKey="Van De Leemput, J" sort="Van De Leemput, J" uniqKey="Van De Leemput J" first="J" last="Van De Leemput">J. Van De Leemput</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000304 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000304 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:2864955 |texte= Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:20437544" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |